NEU-2015.3.31 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
|
| |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2015
OR
|
| |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 1-32190
NEWMARKET CORPORATION
(Exact name of registrant as specified in its charter)
|
| | |
VIRGINIA | | 20-0812170 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| | |
330 SOUTH FOURTH STREET RICHMOND, VIRGINIA | | 23219-4350 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code - (804) 788-5000
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
| | | |
Large accelerated filer | x | Accelerated filer | ¨ |
Non-accelerated filer | ¨ | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No x
Number of shares of common stock, without par value, outstanding as of March 31, 2015: 12,443,241
NEWMARKET CORPORATION
INDEX
PART I. FINANCIAL INFORMATION
ITEM 1. Financial Statements
NEWMARKET CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
|
| | | | | | | | |
(in thousands, except per-share amounts) | | Three Months Ended March 31, |
| | 2015 | | 2014 |
Net sales | | $ | 559,566 |
| | $ | 576,422 |
|
Cost of goods sold | | 378,294 |
| | 414,492 |
|
Gross profit | | 181,272 |
| | 161,930 |
|
Selling, general, and administrative expenses | | 41,809 |
| | 39,548 |
|
Research, development, and testing expenses | | 39,685 |
| | 32,207 |
|
Operating profit | | 99,778 |
| | 90,175 |
|
Interest and financing expenses, net | | 3,816 |
| | 4,164 |
|
Other income (expense), net | | (2,325 | ) | | (2,216 | ) |
Income before income tax expense | | 93,637 |
| | 83,795 |
|
Income tax expense | | 29,690 |
| | 26,272 |
|
Net income | | $ | 63,947 |
| | $ | 57,523 |
|
Earnings per share - basic and diluted | | $ | 5.14 |
| | $ | 4.43 |
|
Cash dividends declared per share | | $ | 1.40 |
| | $ | 1.10 |
|
See accompanying Notes to Consolidated Financial Statements
3
NEWMARKET CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
|
| | | | | | | | |
(in thousands) | | Three Months Ended March 31, |
| | 2015 | | 2014 |
Net income | | $ | 63,947 |
| | $ | 57,523 |
|
Other comprehensive income (loss): | | | | |
Pension plans and other postretirement benefits: | | | | |
Amortization of prior service cost (credit) included in net periodic benefit cost, net of income tax expense (benefit) of $4 in 2015 and $4 in 2014 | | (3 | ) | | (3 | ) |
Amortization of actuarial net loss (gain) included in net periodic benefit cost, net of income tax expense (benefit) of $768 in 2015 and $384 in 2014 | | 1,360 |
| | 707 |
|
Amortization of transition obligation (asset) included in net periodic benefit cost, net of income tax expense (benefit) of $1 in 2014 | | 0 |
| | 2 |
|
Total pension plans and other postretirement benefits | | 1,357 |
| | 706 |
|
Foreign currency translation adjustments, net of income tax expense (benefit) of ($1,098) in 2015 and $985 in 2014 | | (25,664 | ) | | 1,025 |
|
Other comprehensive income (loss) | | (24,307 | ) | | 1,731 |
|
Comprehensive income | | $ | 39,640 |
| | $ | 59,254 |
|
See accompanying Notes to Consolidated Financial Statements
4
NEWMARKET CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
| | | | | | | | |
(in thousands, except share amounts) | | March 31, 2015 | | December 31, 2014 |
ASSETS | | | | |
Current assets: | | | | |
Cash and cash equivalents | | $ | 119,243 |
| | $ | 103,003 |
|
Trade and other accounts receivable, less allowance for doubtful accounts | | 303,334 |
| | 302,803 |
|
Inventories: | | | | |
Finished goods and work-in-process | | 291,866 |
| | 292,214 |
|
Raw materials | | 44,056 |
| | 46,673 |
|
Stores, supplies, and other | | 9,492 |
| | 9,533 |
|
| | 345,414 |
| | 348,420 |
|
Deferred income taxes | | 5,487 |
| | 7,837 |
|
Prepaid expenses and other current assets | | 37,873 |
| | 35,128 |
|
Total current assets | | 811,351 |
| | 797,191 |
|
Property, plant, and equipment, at cost | | 1,025,540 |
| | 1,016,868 |
|
Less accumulated depreciation and amortization | | 706,970 |
| | 709,009 |
|
Net property, plant, and equipment | | 318,570 |
| | 307,859 |
|
Prepaid pension cost | | 16,693 |
| | 16,082 |
|
Deferred income taxes | | 50,544 |
| | 48,499 |
|
Intangibles (net of amortization) and goodwill | | 15,260 |
| | 16,859 |
|
Deferred charges and other assets | | 45,252 |
| | 45,435 |
|
Total assets | | $ | 1,257,670 |
| | $ | 1,231,925 |
|
LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | |
Current liabilities: | | | | |
Accounts payable | | $ | 136,325 |
| | $ | 137,688 |
|
Accrued expenses | | 78,661 |
| | 86,539 |
|
Dividends payable | | 15,738 |
| | 15,721 |
|
Income taxes payable | | 21,237 |
| | 6,462 |
|
Other current liabilities | | 5,173 |
| | 13,264 |
|
Total current liabilities | | 257,134 |
| | 259,674 |
|
Long-term debt | | 373,541 |
| | 363,526 |
|
Other noncurrent liabilities | | 184,105 |
| | 187,684 |
|
Total liabilities | | 814,780 |
| | 810,884 |
|
Commitments and contingencies (Note 7) | |
| |
|
Shareholders’ equity: | | | | |
Common stock and paid-in capital (without par value; authorized shares - 80,000,000; issued and outstanding shares - 12,443,241 at March 31, 2015 and 12,446,365 at December 31, 2014) | | 426 |
| | 0 |
|
Accumulated other comprehensive loss | | (163,467 | ) | | (139,160 | ) |
Retained earnings | | 605,931 |
| | 560,201 |
|
Total shareholders' equity | | 442,890 |
| | 421,041 |
|
Total liabilities and shareholders’ equity | | $ | 1,257,670 |
| | $ | 1,231,925 |
|
See accompanying Notes to Consolidated Financial Statements
5
NEWMARKET CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(Unaudited)
|
| | | | | | | | | | | | | | | | | | | |
(in thousands, except share and per-share amounts) | | Common Stock and Paid-in Capital | | Accumulated Other Comprehensive Loss | | Retained Earnings | | Total Shareholders’ Equity |
| Shares | | Amount | | | |
Balance at December 31, 2013 | | 13,099,356 |
| | $ | 0 |
| | $ | (60,086 | ) | | $ | 632,534 |
| | $ | 572,448 |
|
Net income | |
| |
| |
| | 57,523 |
| | 57,523 |
|
Other comprehensive income (loss) | |
| |
| | 1,731 |
| |
| | 1,731 |
|
Cash dividends ($1.10 per share) | |
| |
| |
| | (14,200 | ) | | (14,200 | ) |
Repurchases of common stock | | (232,200 | ) | | (472 | ) | | | | (81,019 | ) | | (81,491 | ) |
Stock-based compensation | | (121 | ) | | 472 |
| |
| | 2 |
| | 474 |
|
Balance at March 31, 2014 | | 12,867,035 |
| | $ | 0 |
| | $ | (58,355 | ) | | $ | 594,840 |
| | $ | 536,485 |
|
| | | | | | | | | | |
Balance at December 31, 2014 | | 12,446,365 |
| | $ | 0 |
| | $ | (139,160 | ) | | $ | 560,201 |
| | $ | 421,041 |
|
Net income | |
| |
| |
| | 63,947 |
| | 63,947 |
|
Other comprehensive income (loss) | |
| |
| | (24,307 | ) | |
| | (24,307 | ) |
Cash dividends ($1.40 per share) | |
| |
| |
| | (17,421 | ) | | (17,421 | ) |
Repurchases of common stock | | (2,629 | ) | | (232 | ) | | | | (810 | ) | | (1,042 | ) |
Stock-based compensation | | (495 | ) | | 658 |
| |
| | 14 |
| | 672 |
|
Balance at March 31, 2015 | | 12,443,241 |
| | $ | 426 |
| | $ | (163,467 | ) | | $ | 605,931 |
| | $ | 442,890 |
|
See accompanying Notes to Consolidated Financial Statements
6
NEWMARKET CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
| | | | | | | | |
(in thousands) | | Three Months Ended March 31, |
| | 2015 | | 2014 |
Cash and cash equivalents at beginning of year | | $ | 103,003 |
| | $ | 238,703 |
|
Cash flows from operating activities: | | | | |
Net income | | 63,947 |
| | 57,523 |
|
Adjustments to reconcile net income to cash flows from operating activities: | | | | |
Depreciation and amortization | | 10,186 |
| | 10,258 |
|
Noncash pension and postretirement expense | | 5,837 |
| | 3,654 |
|
Deferred income tax expense | | 818 |
| | 1,996 |
|
Unrealized gain on derivative instruments, net | | (95 | ) | | (310 | ) |
Working capital changes | | (13,806 | ) | | (66,764 | ) |
Cash pension and postretirement contributions | | (6,730 | ) | | (5,202 | ) |
Other, net | | (3,605 | ) | | 3,226 |
|
Cash provided from (used in) operating activities | | 56,552 |
| | 4,381 |
|
Cash flows from investing activities: | | | | |
Capital expenditures | | (20,424 | ) | | (9,251 | ) |
Deposits for interest rate swap | | (7,118 | ) | | (1,325 | ) |
Return of deposits for interest rate swap | | 6,750 |
| | 1,580 |
|
Other, net | | (2,503 | ) | | (2,543 | ) |
Cash provided from (used in) investing activities | | (23,295 | ) | | (11,539 | ) |
Cash flows from financing activities: | | | | |
Net borrowings under revolving credit facility | | 10,000 |
| | 6,000 |
|
Dividends paid | | (17,421 | ) | | (14,200 | ) |
Repurchases of common stock | | (1,042 | ) | | (77,061 | ) |
Other, net | | (3,022 | ) | | (161 | ) |
Cash provided from (used in) financing activities | | (11,485 | ) | | (85,422 | ) |
Effect of foreign exchange on cash and cash equivalents | | (5,532 | ) | | 534 |
|
Increase (decrease) in cash and cash equivalents | | 16,240 |
| | (92,046 | ) |
Cash and cash equivalents at end of period | | $ | 119,243 |
| | $ | 146,657 |
|
| | | | |
Supplemental disclosure of non-cash transactions: | | | | |
Additions to property, plant, and equipment included in current liabilities | | $ | 5,433 |
| | $ | 0 |
|
See accompanying Notes to Consolidated Financial Statements
7
NEWMARKET CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Financial Statement Presentation
In the opinion of management, the accompanying consolidated financial statements of NewMarket Corporation and its subsidiaries contain all necessary adjustments for the fair statement of, in all material respects, our consolidated financial position as of March 31, 2015 and December 31, 2014, and our consolidated results of operations, comprehensive income, changes in shareholders' equity, and cash flows for the three months ended March 31, 2015 and March 31, 2014. All adjustments are of a normal, recurring nature, unless otherwise disclosed. These financial statements should be read in conjunction with the consolidated financial statements and related notes included in the NewMarket Corporation Annual Report on Form 10-K for the year ended December 31, 2014 (2014 Annual Report), as filed with the Securities and Exchange Commission. The results of operations for the three month period ended March 31, 2015 are not necessarily indicative of the results to be expected for the full year ending December 31, 2015. The December 31, 2014 consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
Unless the context otherwise indicates, all references to “we,” “us,” “our,” the “company,” and “NewMarket” are to NewMarket Corporation and its consolidated subsidiaries.
Certain reclassifications have been made to the accompanying consolidated financial statements to conform to the current presentation.
2. Segment Information
The tables below show our consolidated segment results. The “All other” category includes the operations of the tetraethyl lead (TEL) business, as well as certain contract manufacturing performed by Ethyl Corporation (Ethyl).
Consolidated Revenue by Segment
|
| | | | | | | | |
| | Three Months Ended March 31, |
(in thousands) | | 2015 | | 2014 |
Petroleum additives | | | | |
Lubricant additives | | $ | 453,722 |
| | $ | 473,349 |
|
Fuel additives | | 101,043 |
| | 100,696 |
|
Total | | 554,765 |
| | 574,045 |
|
All other | | 4,801 |
| | 2,377 |
|
Consolidated revenue | | $ | 559,566 |
| | $ | 576,422 |
|
Segment Operating Profit
|
| | | | | | | | |
| | Three Months Ended March 31, |
(in thousands) | | 2015 | | 2014 |
Petroleum additives | | $ | 105,025 |
| | $ | 96,179 |
|
All other | | 2,099 |
| | 535 |
|
Segment operating profit | | 107,124 |
| | 96,714 |
|
Corporate, general, and administrative expenses | | (7,015 | ) | | (6,553 | ) |
Interest and financing expenses, net | | (3,816 | ) | | (4,164 | ) |
Loss on interest rate swap agreement (a) | | (2,408 | ) | | (2,233 | ) |
Other (expense) income, net | | (248 | ) | | 31 |
|
Income before income tax expense | | $ | 93,637 |
| | $ | 83,795 |
|
| |
(a) | The loss on interest rate swap agreement represents the change, since the beginning of the reporting period, in the fair value of an interest rate swap which we entered into on June 25, 2009. We are not using hedge accounting to record the interest rate swap, and accordingly, any change in the fair value is immediately recognized in earnings. |
3. Pension Plans and Other Postretirement Benefits
The table below shows cash contributions made during the three months ended March 31, 2015, as well as the remaining cash contributions we expect to make during the year ending December 31, 2015, for our domestic and foreign pension plans and domestic postretirement benefit plans.
|
| | | | | | | | |
(in thousands) | | Actual Cash Contributions for Three Months Ended March 31, 2015 | | Expected Remaining Cash Contributions for Year Ending December 31, 2015 |
Domestic plans | | | | |
Pension benefits | | $ | 4,830 |
| | $ | 14,490 |
|
Postretirement benefits | | 340 |
| | 1,019 |
|
Foreign plans | | | | |
Pension benefits | | 1,560 |
| | 4,234 |
|
The tables below present information on net periodic benefit cost (income) for our pension and postretirement benefit plans.
|
| | | | | | | | | | | | | | | | |
| | Domestic |
| | Pension Benefits | | Postretirement Benefits |
| | Three Months Ended March 31, |
(in thousands) | | 2015 | | 2014 | | 2015 | | 2014 |
Service cost | | $ | 3,240 |
| | $ | 2,387 |
| | $ | 711 |
| | $ | 405 |
|
Interest cost | | 2,983 |
| | 2,738 |
| | 757 |
| | 692 |
|
Expected return on plan assets | | (5,092 | ) | | (4,330 | ) | | (322 | ) | | (328 | ) |
Amortization of prior service cost | | 25 |
| | 25 |
| | 0 |
| | 2 |
|
Amortization of actuarial net loss (gain) | | 1,735 |
| | 977 |
| | 0 |
| | (177 | ) |
Net periodic benefit cost (income) | | $ | 2,891 |
| | $ | 1,797 |
| | $ | 1,146 |
| | $ | 594 |
|
|
| | | | | | | | | | | | | | | | |
| | Foreign |
| | Pension Benefits | | Postretirement Benefits |
| | Three Months Ended March 31, |
(in thousands) | | 2015 | | 2014 | | 2015 | | 2014 |
Service cost | | $ | 1,945 |
| | $ | 1,495 |
| | $ | 0 |
| | $ | 2 |
|
Interest cost | | 1,269 |
| | 1,555 |
| | 0 |
| | 24 |
|
Expected return on plan assets | | (1,788 | ) | | (2,079 | ) | | 0 |
| | 0 |
|
Amortization of prior service credit | | (24 | ) | | (26 | ) | | 0 |
| | 0 |
|
Amortization of transition obligation | | 0 |
| | 0 |
| | 0 |
| | 3 |
|
Amortization of actuarial net loss | | 398 |
| | 284 |
| | 0 |
| | 5 |
|
Net periodic benefit cost (income) | | $ | 1,800 |
| | $ | 1,229 |
| | $ | 0 |
| | $ | 34 |
|
4. Earnings Per Share
We had 30,026 shares of nonvested restricted stock at March 31, 2015 and 20,100 shares of nonvested restricted stock at March 31, 2014 that were excluded from the calculation of diluted earnings per share, as their effect on earnings per share would be anti-dilutive.
The nonvested restricted stock is considered a participating security since the restricted stock contains nonforfeitable rights to dividends. As such, we use the two-class method to compute basic and diluted earnings per share for all periods presented since this method yielded a more dilutive result than the treasury-stock method. The following table illustrates the earnings allocation method utilized in the calculation of basic and diluted earnings per share.
|
| | | | | | | | |
| | Three Months Ended March 31, |
(in thousands, except per-share amounts) | | 2015 | | 2014 |
Earnings per share numerator: | | | | |
Net income attributable to common shareholders before allocation of earnings to participating securities | | $ | 63,947 |
| | $ | 57,523 |
|
Earnings allocated to participating securities | | 142 |
| | 90 |
|
Net income attributable to common shareholders after allocation of earnings to participating securities | | $ | 63,805 |
| | $ | 57,433 |
|
Earnings per share denominator: | | | | |
Weighted-average number of shares of common stock outstanding - basic and diluted | | 12,413 |
| | 12,953 |
|
Earnings per share - basic and diluted | | $ | 5.14 |
| | $ | 4.43 |
|
5. Intangibles (Net of Amortization) and Goodwill
The net carrying amount of intangibles and goodwill was $15 million at March 31, 2015 and $17 million at December 31, 2014. The gross carrying amount and accumulated amortization of each type of intangible asset and goodwill are presented in the table below.
|
| | | | | | | | | | | | | | | | |
| | March 31, 2015 | | December 31, 2014 |
(in thousands) | | Gross Carrying Amount | | Accumulated Amortization | | Gross Carrying Amount | | Accumulated Amortization |
Amortizing intangible assets | | | | | | | | |
Formulas and technology | | $ | 88,754 |
| | $ | 83,252 |
| | $ | 88,824 |
| | $ | 82,050 |
|
Contracts | | 4,476 |
| | 3,768 |
| | 4,476 |
| | 3,655 |
|
Customer bases | | 6,983 |
| | 3,409 |
| | 6,994 |
| | 3,336 |
|
Trademarks and trade names | | 1,562 |
| | 808 |
| | 1,571 |
| | 769 |
|
Goodwill | | 4,722 |
| | | | 4,804 |
| | |
| | $ | 106,497 |
| | $ | 91,237 |
| | $ | 106,669 |
| | $ | 89,810 |
|
All of the intangibles relate to the petroleum additives segment. The change in the gross carrying amount between 2014 and 2015 is due to foreign currency fluctuations. There is no accumulated goodwill impairment.
Amortization expense was (in thousands):
|
| | | |
Three months ended March 31, 2015 | $ | 1,427 |
|
Three months ended March 31, 2014 | 1,575 |
|
Estimated amortization expense for the remainder of 2015, as well as annual amortization expense related to our intangible assets for the next five years, is expected to be (in thousands):
|
| | | |
2015 | $ | 4,270 |
|
2016 | 1,891 |
|
2017 | 730 |
|
2018 | 700 |
|
2019 | 678 |
|
2020 | 319 |
|
We amortize contracts over 10 years; customer bases over 20 years; formulas and technology over 10 to 20 years; and trademarks and trade names over 10 years.
6. Long-term Debt
|
| | | | | | | | |
(in thousands) | | March 31, 2015 | | December 31, 2014 |
Senior notes - 4.10% due 2022 | | $ | 349,541 |
| | $ | 349,526 |
|
Revolving credit facility | | 24,000 |
| | 14,000 |
|
| | $ | 373,541 |
| | $ | 363,526 |
|
The outstanding senior notes have an aggregate principal amount of $350 million and are registered under the Securities Act of 1933.
The following table provides information related to the unused portion of our revolving credit facility: |
| | | | | | | | |
(in thousands) | | March 31, 2015 | | December 31, 2014 |
Maximum borrowing capacity under the revolving credit facility | | $ | 650,000 |
| | $ | 650,000 |
|
Outstanding borrowings under the revolving credit facility | | 24,000 |
| | 14,000 |
|
Outstanding letters of credit | | 2,706 |
| | 3,271 |
|
Unused portion of revolving credit facility | | $ | 623,294 |
| | $ | 632,729 |
|
The average interest rate for borrowings under our revolving credit facility was 2.4% during the first three months of 2015 and 2.9% during 2014.
We were in compliance with all covenants under our debt agreements at March 31, 2015 and at December 31, 2014.
7. Commitments and Contingencies
Information on certain commitments and contingencies follows.
Litigation
We are involved in legal proceedings that are incidental to our business and include administrative or judicial actions seeking remediation under environmental laws, such as the federal Comprehensive Environmental Response, Compensation and Liability Act, commonly known as CERCLA or Superfund. Some of these legal proceedings relate to environmental matters and involve governmental authorities. For further information, see “Environmental” below.
While it is not possible to predict or determine with certainty the outcome of any legal proceeding, we believe the outcome of any of these proceedings, or all of them combined, will not result in a material adverse effect on our consolidated results of operations, financial condition, or cash flows.
In 2013, Afton Chemical Corporation (Afton) initiated a voluntary self-audit of its compliance with certain sections of the Toxic Substances Control Act (TSCA) under the Environmental Protection Agency's (EPA) audit policy (Audit Policy). If any potential TSCA violations are discovered during the audit, we would voluntarily disclose them to the EPA under the Audit Policy. In August 2014, the EPA TSCA staff began its own TSCA inspection of both Afton and Ethyl. While it is not possible to predict or determine with certainty the outcome, we do not believe that any findings identified as a result of our audit or the EPA’s TSCA inspection will have a material adverse effect on our consolidated results of operations, financial condition, or cash flows.
As we previously disclosed, the United States Department of Justice advised us that it was conducting a review of certain of our foreign business activities in relation to compliance with relevant U.S. economic sanctions programs and anti-corruption laws, as well as certain historical conduct in the domestic U.S. market, and has requested certain information in connection with such review. We have cooperated with the investigation. In connection with such cooperation, we voluntarily provided certain information and have conducted an internal review for that purpose.
Environmental
We are involved in environmental proceedings and potential proceedings relating to soil and groundwater contamination, disposal of hazardous waste, and other environmental matters at several of our current or former facilities, or at third-party sites where we have been designated as a potentially responsible party (PRP). While we believe we are currently adequately accrued for known environmental issues, it is possible that unexpected future costs could have a significant impact on our financial position, results of operations, and cash flows. Our total accruals for environmental remediation, dismantling, and decontamination were approximately $18 million at both March 31, 2015 and December 31, 2014.
Our more significant environmental sites include a former TEL plant site in Louisiana (the Louisiana site) and a former Houston, Texas plant site (the Texas site). Together, the amounts accrued on a discounted basis related to these sites represent approximately $11 million of the total accrual above at both March 31, 2015 and December 31, 2014, using discount rates ranging from 3% to 9%. Of the total accrued for these two sites, the amount related to remediation of groundwater and soil was $5 million for the Louisiana site at both March 31, 2015 and December 31, 2014. The amount related to remediation of groundwater and soil for the Texas site was $5 million at March 31, 2015 and $6 million at December 31, 2014. The aggregate undiscounted amount for these sites was $15 million at both March 31, 2015 and December 31, 2014.
In 2000, the EPA named us as a PRP under Superfund law for the clean-up of soil and groundwater contamination at the five grouped disposal sites known as "Sauget Area 2 Sites" in Sauget, Illinois. Without admitting any fact, responsibility, fault, or liability in connection with this site, we are participating with other PRPs in site investigations and feasibility studies. In December 2013, the EPA issued its Record of Decision confirming its remedies for the selected Sauget Area 2 sites. We have accrued our estimated proportional share of the remedial costs and expenses addressed in the Record of Decision. We do not believe there is any additional information available as a basis for revision of the liability that we have established at March 31, 2015. The amount accrued for this site is not material.
8. Derivatives and Hedging Activities
We are exposed to certain risks arising from both our business operations and economic conditions. We primarily manage our exposures to a wide variety of business and operational risks through management of our core business activities.
We manage certain economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of our debt funding, as well as through the use of derivative financial instruments. Specifically, we have entered, and may enter in the future, into interest rate swaps to manage our exposure to interest rate movements.
Our foreign operations expose us to fluctuations of foreign exchange rates. These fluctuations may impact our results of operations, financial position, and cash flows. To manage this exposure, we sometimes enter into foreign currency forward contracts to minimize currency exposure due to cash flows from foreign operations. There were no such contracts outstanding at March 31, 2015 or December 31, 2014.
Non-designated Hedges
On June 25, 2009, we entered into an interest rate swap with Goldman Sachs in the notional amount of $97 million and with a maturity date of January 19, 2022 (Goldman Sachs interest rate swap). NewMarket entered into the Goldman Sachs interest rate swap in connection with the termination of a loan application and related rate lock agreement between Foundry Park I and Principal Commercial Funding II, LLC (Principal). When the rate lock agreement was originally executed in 2007, Principal simultaneously entered into an interest rate swap with a third party to hedge Principal’s exposure to fluctuation in the ten-year United States Treasury Bond rate. Upon the termination of the rate lock agreement on June 25, 2009, Goldman Sachs both assumed Principal’s position with the third party and entered into an offsetting interest rate swap with NewMarket. Under the terms of this interest rate swap, NewMarket is making fixed rate payments at 5.3075% and Goldman Sachs makes variable rate payments based on three-month LIBOR. We have collateralized this exposure through cash deposits posted with Goldman Sachs amounting to $28 million at both March 31, 2015 and December 31, 2014.
We have made an accounting policy election to not offset derivative fair value amounts with the fair value amounts for the right to reclaim cash collateral under our master netting arrangement. We do not use hedge accounting for the Goldman Sachs interest rate swap, and therefore, immediately recognize any change in the fair value of this derivative financial instrument directly in earnings.
The table below presents the fair value of our derivative financial instruments, as well as their classification on the Consolidated Balance Sheets.
|
| | | | | | | | | | | | |
| | Liability Derivatives |
| | March 31, 2015 | | December 31, 2014 |
(in thousands) | | Balance Sheet Location | | Fair Value | | Balance Sheet Location | | Fair Value |
Derivatives Not Designated as Hedging Instruments | | | | | | | | |
Goldman Sachs interest rate swap | | Accrued expenses and Other noncurrent liabilities | | $ | 23,294 |
| | Accrued expenses and Other noncurrent liabilities | | $ | 23,389 |
|
The following table presents the effect of our derivative financial instruments on the Consolidated Statements of Income.
Effect of Derivative Instruments on the Consolidated Statements of Income
Non-Designated Derivatives
(in thousands)
|
| | | | | | | | | | |
Derivatives Not Designated as Hedging Instruments | | Location of Gain (Loss) Recognized in Income on Derivatives | | Amount of Gain (Loss) Recognized in Income on Derivatives |
| | | | Three Months Ended March 31, |
| | | | 2015 | | 2014 |
Goldman Sachs interest rate swap | | Other income (expense), net | | $ | (2,408 | ) | | $ | (2,233 | ) |
Credit-risk Related Contingent Features
The agreement we have with our current derivative counterparty contains a provision where we could be declared in default on our derivative obligation if repayment of indebtedness is accelerated by our lender(s) due to our default on the indebtedness.
As of March 31, 2015, the fair value of the derivative in a net liability position related to this agreement, which includes accrued interest but excludes any adjustment for nonperformance risk, was $23 million. We have minimum collateral posting thresholds with the counterparty and have posted cash collateral of $28 million as of March 31, 2015. If required, we could have settled our obligations under the agreement at the termination value of $23 million at March 31, 2015.
9. Other Comprehensive Income (Loss) and Accumulated Other Comprehensive Loss
The balances of, and changes in, the components of accumulated other comprehensive loss, net of tax, consist of the following:
|
| | | | | | | | | | | | |
(in thousands) | | Pension Plans and Other Postretirement Benefits | | Foreign Currency Translation Adjustments | | Accumulated Other Comprehensive (Loss) Income |
Balance at December 31, 2013 | | $ | (44,493 | ) | | $ | (15,593 | ) | | $ | (60,086 | ) |
Other comprehensive income (loss) before reclassifications | | 0 |
| | 1,025 |
| | 1,025 |
|
Amounts reclassified from accumulated other comprehensive loss (a) | | 706 |
| | 0 |
| | 706 |
|
Other comprehensive income (loss) | | 706 |
| | 1,025 |
| | 1,731 |
|
Balance at March 31, 2014 | | $ | (43,787 | ) | | $ | (14,568 | ) | | $ | (58,355 | ) |
| | | | | | |
Balance at December 31, 2014 | | $ | (95,119 | ) | | $ | (44,041 | ) | | $ | (139,160 | ) |
Other comprehensive income (loss) before reclassifications | | 0 |
| | (25,664 | ) | | (25,664 | ) |
Amounts reclassified from accumulated other comprehensive loss (a) | | 1,357 |
| | 0 |
| | 1,357 |
|
Other comprehensive income (loss) | | 1,357 |
| | (25,664 | ) | | (24,307 | ) |
Balance at March 31, 2015 | | $ | (93,762 | ) | | $ | (69,705 | ) | | $ | (163,467 | ) |
(a) These pension plans and other postretirement benefits components of accumulated other comprehensive loss are included in the computation of net periodic benefit cost (income). See Note 3 in this Form 10-Q and Note 18 in our 2014 Annual Report for further information.
10. Fair Value Measurements
The following table provides information on assets and liabilities measured at fair value on a recurring basis. No material events occurred during the three months ended March 31, 2015 requiring adjustment to the recognized balances of assets or liabilities which are recorded at fair value on a nonrecurring basis.
|
| | | | | | | | | | | | | | | | | | | | |
| | Carrying Amount in Consolidated Balance Sheets | | | | Fair Value Measurements Using |
| | | Fair Value | | Level 1 | | Level 2 | | Level 3 |
(in thousands) | | March 31, 2015 |
Cash and cash equivalents | | $ | 119,243 |
| | $ | 119,243 |
| | $ | 119,243 |
| | $ | 0 |
| | $ | 0 |
|
Cash deposit for collateralized interest rate swap | | 28,151 |
| | 28,151 |
| | 28,151 |
| | 0 |
| | 0 |
|
Interest rate swap liability | | 23,294 |
| | 23,294 |
| | 0 |
| | 23,294 |
| | 0 |
|
| | | | | | | | | | |
| | | | | | | | | | |
| | December 31, 2014 |
Cash and cash equivalents | | $ | 103,003 |
| | $ | 103,003 |
| | $ | 103,003 |
| | $ | 0 |
| | $ | 0 |
|
Cash deposit for collateralized interest rate swap | | 27,783 |
| | 27,783 |
| | 27,783 |
| | 0 |
| | 0 |
|
Interest rate swap liability | | 23,389 |
| | 23,389 |
| | 0 |
| | 23,389 |
| | 0 |
|
We determine the fair value of the derivative instrument shown in the table above by using widely-accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of the instrument. The analysis reflects the contractual term of the derivative, including the period to maturity, and uses observable market-based inputs.
The fair value of the interest rate swap is determined using the market standard methodology of netting the discounted future fixed cash receipts and the discounted expected variable cash payments. The variable cash payments are based on an expectation of future interest rates derived from observable market interest rate curves. In determining the fair value measurements, we incorporate credit valuation adjustments to appropriately reflect both our nonperformance risk and the counterparties’ nonperformance risk.
Although we have determined that the majority of the inputs used to value our derivative fall within Level 2 of the fair value hierarchy, the credit valuation adjustment associated with the derivative utilizes Level 3 inputs. These Level 3 inputs include estimates of current credit spreads to evaluate the likelihood of default by both us and the counterparties to the derivative. As of March 31, 2015 and December 31, 2014, we have assessed the significance of the impact of the credit valuation adjustment on the overall valuation of our derivative and have determined that the credit valuation adjustment is not significant to the overall valuation of the derivative. Accordingly, we have determined that our derivative valuation should be classified in Level 2 of the fair value hierarchy.
We have made an accounting policy election to measure credit risk of any derivative financial instruments subject to master netting agreements on a net basis by counterparty portfolio.
Long-term debt – We record the value of our long-term debt at historical cost. The estimated fair value of our long-term debt is shown in the table below and is based primarily on estimated current rates available to us for debt of the same remaining duration and adjusted for nonperformance risk and credit risk. The estimated fair value is determined by the market standard practice of modeling the contractual cash flows required under the debt instrument and discounting the cash flows back to present value at the appropriate credit-risk adjusted market interest rates. For floating rate debt obligations, we use forward rates, derived from observable market yield curves, to project the expected cash flows we will be required to make under the debt instrument. We then discount those cash flows back to present value at the appropriate credit-risk adjusted market interest rates. The fair value is categorized as Level 2.
|
| | | | | | | | | | | | | | | | |
| | March 31, 2015 | | December 31, 2014 |
(in thousands) | | Carrying Amount | | Fair Value | | Carrying Amount | | Fair Value |
Long-term debt | | $ | 373,541 |
| | $ | 417,582 |
| | $ | 363,526 |
| | $ | 388,581 |
|
11. Recently Issued Accounting Pronouncements
In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” (ASU 2014-09). ASU 2014-09 replaces the previous guidance and clarifies the principles for revenue recognition. It requires a five-step process for revenue recognition that represents the transfer of goods or services to customers in an amount that reflects the consideration expected to be received by a company. ASU 2014-09 also requires enhanced disclosures regarding the nature, amount, timing, and uncertainty of revenues and cash flows from contracts with customers. ASU 2014-09 is currently effective for our reporting period beginning January 1, 2017, and early adoption is prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. During April 2015, the FASB voted to propose a delay of one year in the effective date of ASU 2014-09. A final decision on the effective date is expected during the second quarter of 2015. We are currently assessing the impact that the adoption of ASU 2014-09 will have on our consolidated financial statements.
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
This report contains forward-looking statements about future events and expectations within the meaning of the Private Securities Litigation Reform Act of 1995. We have based these forward-looking statements on our current expectations and projections about future results. When we use words in this document such as “anticipates,” “intends,” “plans,” “believes,” “estimates,” “projects,” “expects,” “should,” “could,” “may,” “will,” and similar expressions, we do so to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements we make regarding future prospects of growth in the petroleum additives market, other trends in the petroleum additives market, our ability to maintain or increase our market share, and our future capital expenditure levels.
We believe our forward-looking statements are based on reasonable expectations and assumptions, within the bounds of what we know about our business and operations. However, we offer no assurance that actual results will not differ materially from our expectations due to uncertainties and factors that are difficult to predict and beyond our control.
Factors that could cause actual results to differ materially from expectations include, but are not limited to, availability of raw materials and distribution systems; disruptions at manufacturing facilities, including single-sourced facilities; ability to respond effectively to technological changes in our industry; failure to protect our intellectual property rights; failure to attract and retain a highly-qualified workforce; hazards common to chemical businesses; competition from other manufacturers; sudden or sharp raw materials price increases; gain or loss of significant customers; occurrence or threat of extraordinary events, including natural disasters and terrorist attacks; risks related to operating outside of the United States; the impact of fluctuations in foreign exchange rates; an information technology system failure; political, economic, and regulatory factors concerning our products; future governmental regulation; resolution of environmental liabilities or legal proceedings; inability to complete future acquisitions or successfully integrate future acquisitions into our business; and other factors detailed from time to time in the reports that NewMarket files with the Securities and Exchange Commission, including the risk factors in Item 1A. “Risk Factors” of our 2014 Annual Report on Form 10-K (2014 Annual Report), which is available to shareholders upon request.
You should keep in mind that any forward-looking statement made by us in this report speaks only as of the date on which we make it. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. We have no duty to, and do not intend to, update or revise the forward-looking statements in this discussion after the date hereof, except as may be required by law. In light of these risks and uncertainties, any forward-looking statement made in this report might not occur.
Overview
During the first three months of 2015, our business continued to perform well. Operating profits remained steady, and while revenue was down primarily due to foreign currency impacts, product shipments increased over the first three months of 2014. We continue to invest in organizational talent, technology development/processes, and global infrastructure, consisting of technical centers and production capacity, in support of our business. In addition, our cash flow generation was sufficient to fund operations, including increased working capital requirements. We continue to manage our business for the long-run with the goal of helping our customers succeed in their marketplaces.
Also, during the first three months of 2015, we repurchased 2,629 shares of our common stock at a total cost of $1.0 million.
Results of Operations
Revenue
Consolidated revenue for the first three months of 2015 totaled $559.6 million, representing a decrease of approximately 2.9% from the first three months of 2014 of $576.4 million. The following table shows revenue by segment and product line.
|
| | | | | | | | |
| | Three Months Ended March 31, |
(in millions) | | 2015 | | 2014 |
Petroleum additives | | | | |
Lubricant additives | | $ | 453.7 |
| | $ | 473.3 |
|
Fuel additives | | 101.1 |
| | 100.7 |
|
Total | | 554.8 |
| | 574.0 |
|
All other | | 4.8 |
| | 2.4 |
|
Consolidated revenue | | $ | 559.6 |
| | $ | 576.4 |
|
Petroleum Additives Segment
The regions in which we operate include North America (the United States and Canada), Latin America (Mexico, Central America, and South America), Asia Pacific, and the Europe/Middle East/Africa/India (EMEAI) region. While there is some fluctuation, the percentage of revenue generated in the regions remained fairly consistent when comparing the first three months of 2015 with the same period in 2014, as well as with the full year in 2014. In addition, the percentage of lubricant additives sales and fuel additives sales is also substantially consistent between periods.
Petroleum additives net sales for the first three months of 2015 of $554.8 million decreased $19.2 million, or approximately 3.4%, from $574.0 million for the first three months of 2014. The North America and Latin America regions reflected increased revenue when comparing the two periods of 2015 and 2014, which was more than offset by decreases in net sales in the Asia Pacific and EMEAI regions when comparing the two periods.
Most of the decrease in petroleum additives net sales resulted from an unfavorable foreign currency impact when comparing the first three months of 2015 with the first three months of 2014. The U.S. Dollar strengthened against all of the major currencies in which we transact, including the European Union Euro, the British Pound Sterling, and the Japanese Yen.
Overall, petroleum additives product shipments increased in the first three months of 2015 and were approximately 1.5% higher than the first three months of 2014. Lubricant additives product shipments were down slightly on a worldwide basis, but were higher in North America and Latin America for the first three months of 2015. Fuel additives product shipments on a worldwide basis increased over three months 2014 levels, with over 80% of the increase in the North America region.
Selling prices had a negligible impact on the change in petroleum additives net sales between the 2015 and 2014 three month periods.
The following table details the approximate components of the decrease in net sales between the first three months of 2015 and 2014.
|
| | | | |
(in millions) | | Three Months |
Period ended March 31, 2014 | | $ | 574.0 |
|
Lubricant additives shipments | | (4.3 | ) |
Fuel additives shipments | | 5.8 |
|
Selling prices, including changes in customer mix | | 0.5 |
|
Foreign currency impact, net | | (21.2 | ) |
Period ended March 31, 2015 | | $ | 554.8 |
|
All Other
The “All other” category includes the operations of the TEL business and certain contract manufacturing performed by Ethyl.
Segment Operating Profit
NewMarket evaluates the performance of the petroleum additives business based on segment operating profit. NewMarket Services Corporation (NewMarket Services) expenses are charged to NewMarket and each subsidiary pursuant to services agreements between the companies. Depreciation on segment property, plant, and equipment, as well as amortization of segment intangible assets, is included in segment operating profit.
The following table reports segment operating profit for the three months ended March 31, 2015 and March 31, 2014.
|
| | | | | | | | |
| | Three Months Ended March 31, |
(in millions) | | 2015 | | 2014 |
Petroleum additives | | $ | 105.0 |
| | $ | 96.2 |
|
All other | | $ | 2.1 |
| | $ | 0.5 |
|
Petroleum Additives Segment
The petroleum additives segment operating profit increased $8.8 million when comparing the first three months of 2015 to the first three months of 2014, and included the impact of decreases in raw material costs. Operating profit from both lubricant additives and fuel additives products increased for the three month period in 2015 compared to the same three months in 2014. The operating profit margin was 18.9% for the three months of 2015 as compared to 16.8% for the three months of 2014. For the rolling four quarters ended March 31, 2015, the operating profit margin for petroleum additives was 17.1%, which is in line with our expectations of the performance of our business over the long-term. While operating profit margins will fluctuate from quarter to quarter due to multiple factors, we do not operate our business differently from quarter to quarter. We believe the fundamentals of our business and industry are unchanged. We continue to focus on developing and delivering innovative, technology-driven solutions to our customers.
Gross profit results increased $18.1 million when comparing the first three months of 2015 and 2014. Cost of sales as a percentage of revenue was 67.8% for the three months of 2015, down from 72.1% for the three months of 2014.
When comparing the first three months of 2015 and 2014, the primary factor in the improvement in gross profit resulted from a favorable raw material variance which contributed over 100% of the change. Costs for our primary raw materials were lower during the first three months of 2015 than the first three months of 2014. The volume variance in product shipments, as discussed in the Revenue section above, as well as conversion costs, was also favorable for the 2015 three month period. Partially offsetting these favorable variances was an unfavorable sales price variance, which included the unfavorable impact from foreign currency rates as discussed in the Revenue section above.
Selling, general, and administrative expenses (SG&A) for the three months of 2015 were $1.9 million, or 5.9%, higher than the three months of 2014. SG&A as a percentage of revenue was 6.1% for the three months of 2015, and 5.6% for the three months of 2014. Our SG&A costs are primarily personnel-related and include salaries, benefits, and other costs associated with our workforce. There were no significant changes in these costs when comparing the two periods.
Research, development, and testing expenses (R&D) for the three months of 2015 increased $7.5 million, or 23.2%, from the three months of 2014. Most of the increase was in support of the lubricant additives product line. The increase in R&D spending reflects our efforts to support the development of additives that meet our customers' needs, as well as new standards, and to expand into new product solution areas. As a percentage of revenue, R&D was 7.2% for the three months of 2015 compared to 5.6% for the three months of 2014. Our approach to R&D investment, as it is with SG&A, is one of purposeful spending on programs to support our current product base and to ensure that we develop products to support our customers' programs in the future. R&D expenses include personnel-related costs, as well as internal and external testing of our products. Our expectation is that R&D will increase for the full year of 2015 as compared to 2014.
The following discussion references the Consolidated Financial Statements beginning on page 3 of this Quarterly Report on Form 10-Q.
Interest and Financing Expenses
Interest and financing expenses were $3.8 million for the first three months of 2015 and $4.2 million for the first three months of 2014. The small decrease in interest and financing expenses between the three month periods resulted primarily from lower fees and amortization.
Other Income (Expense), Net
Other income (expense), net was $2.3 million expense for the first three months of 2015, and $2.2 million expense for the first three months of 2014. The amounts for both periods reflected the impact from a derivative instrument representing an interest rate swap recorded at fair value through earnings. See Note 8 for additional information on the interest rate swap.
Income Tax Expense
Income tax expense was $29.7 million for the first three months of 2015 and $26.3 million for the first three months of 2014. The effective tax rate was 31.7% for the three months of 2015 and 31.4% for the three months of 2014. The increase in income before income tax expense resulted in $3.1 million of the higher income tax expense. The higher effective tax rate in 2015 as compared to 2014 resulted in the remaining increase in income taxes when comparing the two three month periods.
The effective tax rate for both the 2015 and 2014 periods included the benefit of income in foreign jurisdictions with lower tax rates than the United States tax rate, as well as a substantial benefit from the domestic manufacturing tax deduction. Neither the 2015 nor 2014 tax rates included a benefit for the research and development tax credit, as this credit had not been extended to either year by the United States Congress at the end of the two reporting periods.
Cash Flows, Financial Condition, and Liquidity
Cash and cash equivalents at March 31, 2015 were $119.2 million, which was an increase of $16.2 million since December 31, 2014.
Cash and cash equivalents held by our foreign subsidiaries amounted to approximately $113.3 million at March 31, 2015 and $100.2 million at December 31, 2014. A significant amount, but not all, of these foreign cash balances are associated with earnings that we have asserted are indefinitely reinvested. We plan to use these indefinitely reinvested earnings to support growth outside of the United States through funding of operating expenses, R&D expenses, capital expenditures, and other cash needs of our foreign subsidiaries. Periodically, we repatriate cash from our foreign subsidiaries to the United States through intercompany dividends. These intercompany dividends are paid only by subsidiaries whose earnings we have not asserted are indefinitely reinvested or whose earnings qualify as previously taxed income, as defined by the Internal Revenue Code. If circumstances were to change that would cause these indefinitely reinvested earnings to be repatriated, an incremental U.S. tax liability would be incurred. As part of our foreign subsidiary repatriation activities, we received cash dividends of $2.0 million for the three months ended March 31, 2014. We received no cash dividends from foreign subsidiaries during the three months ended March 31, 2015.
We expect that cash from operations, together with borrowing available under our revolving credit facility, will continue to be sufficient to cover our operating needs for the foreseeable future.
Cash Flows – Operating Activities
Cash flows provided from operating activities for the first three months of 2015 was $56.6 million, including a decrease of $13.8 million due to higher working capital requirements. The higher working capital requirements excluded an unfavorable foreign currency impact to the components of working capital on the balance sheet of approximately $14.5 million.
Including the impact of foreign currency on the balance sheet, the most significant effects to the change in working capital resulted from increased income taxes payable, partially offset by a decrease in accrued expenses. The increase in income taxes payable is the result of normal timing of estimated payments. The decrease in accrued expenses primarily reflects payments related to customer rebates, as well as other payments made in the first quarter of each year.
Including cash and cash equivalents, we had total working capital of $554.2 million at March 31, 2015 and $537.5 million at December 31, 2014. The current ratio was 3.16 to 1 at March 31, 2015 and 3.07 to 1 at December 31, 2014.
Cash Flows – Investing Activities
Cash used in investing activities was $23.3 million during the first three months of 2015 and included $20.4 million for capital expenditures. We estimate our total capital spending during 2015 will be approximately $100 million to $140 million, including anticipated spending on a new manufacturing facility in Singapore, as well as several improvements to our manufacturing and R&D infrastructure around the world. We expect to continue to finance capital spending through cash on hand and cash provided from operations, together with borrowing available under our $650 million revolving credit facility.
Cash Flows – Financing Activities
Cash used in financing activities during the first three months of 2015 amounted to $11.5 million. The cash was used to repurchase $1.0 million of our common stock and to pay dividends of $17.4 million. We borrowed $10.0 million under our revolving credit facility during the first three months of 2015.
We had total long-term debt of $373.5 million at March 31, 2015, representing an increase of approximately $10.0 million in our total long-term debt since December 31, 2014, due to borrowing $10.0 million on our revolving credit facility.
At March 31, 2015, in addition to the revolving credit facility which is discussed below, we had outstanding senior notes in the aggregate principal amount of $350 million that bear interest at a fixed rate of 4.10% and are due in 2022. These senior notes are registered under the Securities Act of 1933.
Revolving Credit Facility – At March 31, 2015, we had a $650 million multicurrency revolving credit facility, with a $100 million sublimit for multicurrency borrowings, a $75 million sublimit for letters of credit, and a $20 million sublimit for swingline loans. The agreement includes an expansion feature, which allows us, subject to certain conditions, to request an increase to the aggregate amount of the revolving credit facility or obtain incremental term loans in an amount up to $150 million. Borrowings bear interest at variable rates. The revolving credit facility matures on October 28, 2019.
The following table provides information related to the unused portion of our revolving credit facility:
|
| | | | | | | | |
(in millions) | | March 31, 2015 | | December 31, 2014 |
Maximum borrowing capacity under the revolving credit facility | | $ | 650.0 |
| | $ | 650.0 |
|
Outstanding borrowings under the revolving credit facility | | 24.0 |
| | 14.0 |
|
Outstanding letters of credit | | 2.7 |
| | 3.3 |
|
Unused portion of revolving credit facility | | $ | 623.3 |
| | $ | 632.7 |
|
Both the 4.10% senior notes and the revolving credit facility contain covenants, representations, and events of default that management considers typical of credit arrangements of this nature. The more restrictive and significant financial covenants under the revolving credit facility include:
•A consolidated Leverage Ratio (as defined in the credit agreement) of no more than 3.50 to 1.00; and
•A consolidated Interest Coverage Ratio (as defined in the credit agreement) of no less than 3.00 to 1.00, calculated on a rolling four quarter basis.
At March 31, 2015, the Leverage Ratio was 0.92 and the Interest Coverage Ratio was 22.74, while at December 31, 2014 the Leverage Ratio was 0.93 and the Interest Coverage Ratio was 21.65. We were in compliance with all covenants under both the revolving credit facility and the 4.10% senior notes at March 31, 2015 and December 31, 2014.
As a percentage of total capitalization (total long-term debt and shareholders’ equity), our total long-term debt percentage decreased from 46.3% at December 31, 2014 to 45.8% at March 31, 2015. The change in the percentage was primarily the result of the increase in shareholders’ equity, partially offset by the increase in long-term debt. The increase in shareholders’ equity reflects our earnings, offset by the impact of dividend payments, stock repurchases, and changes in the foreign currency translation adjustment. Normally, we repay any outstanding long-term debt with cash from operations or refinancing activities.
Critical Accounting Policies and Estimates
This Form 10-Q and our 2014 Annual Report include discussions of our accounting policies, as well as methods and estimates used in the preparation of our financial statements. We also provide a discussion of Critical Accounting Policies and Estimates in our 2014 Annual Report. We believe these discussions and financial statements fairly represent the financial position and results of operations of our company in all material respects.
There have been no significant changes in our critical accounting policies and estimates from those reported in our 2014 Annual Report.
Recently Issued Accounting Pronouncements
For a full discussion of the more significant recently issued accounting pronouncement which may impact our financial statements, see Note 11.
Outlook
We are pleased with our performance and operational results for the first three months of 2015. The results reinforce our confidence in our customer-focused strategy and approach to the market. We continue to believe the fundamentals of how we run our business - a long-term view, safety-first culture, customer-focused/technology-driven solutions, world-class supply chain capability, and a regional organizational structure to better understand what our customers value - will continue to be beneficial for all of our stakeholders.
We continue to have expectations that our petroleum additives segment will deliver solid performance in 2015, after having posted record operating profit for each of the last several years. We expect that the petroleum additives industry
shipment demand will continue to grow at an average annual rate of 1% to 2% over the foreseeable future, as there have been no significant changes in the positive fundamentals of the industry. Over the long-term, we plan to exceed the industry growth rate. We have made significant investments to expand our capabilities around the world over the last few years, which will continue into 2015. These investments have been and will continue to be in organizational talent, technology development/processes and global infrastructure, consisting of technical centers, production capacity, and geographic expansion. In 2014, we broke ground on our new Singapore manufacturing facility, continuing our commitment to global investment in support of our customers. We intend to utilize these new capabilities to improve our ability to deliver the solutions that our customers value and to expand our global reach and improve profits. We will continue to invest in our capabilities to provide even better service, technology, and customer solutions.
Our business continues to generate significant amounts of cash beyond what is necessary for the expansion and growth of our current offerings. We regularly review our many internal opportunities to utilize this cash from technological, geographic, and product line perspectives. Our primary focus in the acquisition area remains on the petroleum additives industry. It is our view that this industry will provide the greatest opportunity for solid returns on our investments while minimizing risk. We remain focused on this strategy and will evaluate any future opportunities. Nonetheless, we are patient in this pursuit and intend to make the right acquisition when the opportunity arises. We will continue to evaluate all alternative uses of cash to enhance shareholder value, including stock repurchases and dividends.
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk
At March 31, 2015, there were no significant changes in our market risk from the information provided in the 2014 Annual Report.
ITEM 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain a system of internal control over financial reporting to provide reasonable, but not absolute, assurance of the reliability of the financial records and the protection of assets. Our controls and procedures include written policies and procedures, careful selection and training of qualified personnel, and an internal audit program. We use third-party firms, separate from our independent registered public accounting firm, to assist with internal audit services.
We work closely with the business groups, operations personnel, and information technology to ensure transactions are recorded properly. Environmental and legal staff are consulted to determine the appropriateness of our environmental and legal liabilities for each reporting period. We regularly review the regulations and rule changes that affect our financial disclosures.
Our disclosure controls and procedures include signed representation letters from our regional officers, as well as senior management.
We have a Financial Disclosure Committee (the committee), which is made up of the president of Afton, the general counsel of NewMarket, and the controller of NewMarket. The committee makes representations with regard to the financial statements that, to the best of their knowledge, the statements do not contain any misstatement of a material fact or omit a material fact that is necessary to make the statements not misleading with respect to the periods covered by the report. They also represent that, to the best of their knowledge, the financial statements fairly present, in all material respects, our financial condition, results of operations, and cash flows as of and for the periods presented in the report.
Management personnel from our geographic regions also represent that, to the best of their knowledge, the financial statements and other financial information from their respective regions, which are included in our consolidated financial statements, fairly present, in all material respects, the financial condition and results of operations of their respective regions as of and for the periods presented in the report.
Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (the Exchange Act), we carried out an evaluation, with the participation of our management, including our principal executive officer and our principal financial officer, of the effectiveness of our disclosure controls and procedures, as such term is defined in Rule 13a-15(e) under the Exchange Act, as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures are effective.
There has been no change in our internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act, during the quarter ended March 31, 2015, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
ITEM 1. Legal Proceedings
We are involved in legal proceedings that are incidental to our business and include administrative or judicial actions seeking remediation under environmental laws, such as the federal Comprehensive Environmental Response, Compensation and Liability Act, commonly known as CERCLA or Superfund. Some of these legal proceedings relate to environmental matters and involve governmental authorities. For further information, see “Environmental” in Note 7.
While it is not possible to predict or determine with certainty the outcome of any legal proceeding, we believe the outcome of any of these proceedings, or all of them combined, will not result in a material adverse effect on our consolidated results of operations, financial condition, or cash flows.
In late 2013, Afton initiated a voluntary self-audit of its compliance with certain sections of TSCA under the EPA’s Audit Policy. If any potential TSCA violations are discovered during the audit, we would voluntarily disclose them to the EPA under the Audit Policy. In August 2014, the EPA TSCA staff began its own TSCA inspection of both Afton and Ethyl. While it is not possible to predict or determine with certainty the outcome, we do not believe that any findings identified as a result of our audit or the EPA’s TSCA inspection will have a material adverse effect on our consolidated results of operations, financial condition, or cash flows.
As we previously disclosed, the United States Department of Justice has advised us that it was conducting a review of certain of our foreign business activities in relation to compliance with relevant U.S. economic sanctions programs and anti-corruption laws, as well as certain historical conduct in the domestic U.S. market, and requested certain information in connection with such review. We have cooperated with the investigation. In connection with such cooperation, we voluntarily provided certain information and have conducted an internal review for that purpose.
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
On April 24, 2014, our Board of Directors approved a share repurchase program authorizing management to repurchase up to $400 million of NewMarket's outstanding common stock until December 31, 2016, as market conditions warrant and covenants under our existing agreements permit. We may conduct the share repurchases in the open market and in privately negotiated transactions. The repurchase program does not require NewMarket to acquire any specific number of shares and may be terminated or suspended at any time. Approximately $256 million remained available under the 2014 authorization at March 31, 2015. The following table outlines the purchases during the first quarter of 2015 under this authorization.
Issuer Purchases of Equity Securities
|
| | | | | | | | | | | | |
Period | | Total Number of Shares Purchased | | Average Price Paid per Share | | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs |
January 1 to January 31 | | 2,629 | | $ | 396.44 |
| | 2,629 | | $ | 255,650,185 |
|
February 1 to February 28 | | 0 | | 0.00 |
| | 0 | | 255,650,185 |
|
March 1 to March 31 | | 0 | | 0.00 |
| | 0 | | 255,650,185 |
|
Total | | 2,629 | | 396.44 |
| | 2,629 | | 255,650,185 |
|
ITEM 6. Exhibits
|
| |
Exhibit 3.1 | Articles of Incorporation Amended and Restated effective April 27, 2012 (incorporated by reference to Exhibit 3.1 to Form 8-K (File No. 1-32190) filed April 30, 2012) |
Exhibit 3.2 | NewMarket Corporation Bylaws Amended and Restated effective February 26, 2015 (incorporated by reference to Exhibit 3.1 to Form 8-K (File No. 1- 32190) filed February 26, 2015) |
Exhibit 31(a) | Certification pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Thomas E. Gottwald |
Exhibit 31(b) | Certification pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Brian D. Paliotti |
Exhibit 32(a) | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Thomas E. Gottwald |
Exhibit 32(b) | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Brian D. Paliotti |
Exhibit 101 | XBRL Instance Document and Related Items |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
| |
| NEWMARKET CORPORATION |
| (Registrant) |
| |
Date: April 29, 2015 | By: /s/ Brian D. Paliotti |
| Brian D. Paliotti |
| Vice President and |
| Chief Financial Officer |
| (Principal Financial Officer) |
| |
Date: April 29, 2015 | By: /s/ William J. Skrobacz |
| William J. Skrobacz |
| Controller |
| (Principal Accounting Officer) |
EXHIBIT INDEX
|
| |
Exhibit 31(a) | Certification pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Thomas E. Gottwald |
Exhibit 31(b) | Certification pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Brian D. Paliotti |
Exhibit 32(a) | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Thomas E. Gottwald |
Exhibit 32(b) | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Brian D. Paliotti |
Exhibit 101 | XBRL Instance Document and Related Items |